Breaking News Instant updates and real-time market news.

RAD

Rite Aid

$2.69

-0.205 (-7.09%)

, DERM

Dermira

$28.73

-1.44 (-4.77%)

10:32
06/30/17
06/30
10:32
06/30/17
10:32

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Rite Aid (RAD) reinstated with an Underperform at Evercore ISI. 2. Hill-Rom (HRC) initiated with a Buy at Needham and Neutral at Cantor. 3. Dermira (DERM) initiated with an Outperform at Evercore ISI. 4. Coach (COH) initiated with a Buy at Canaccord. 5. WWE (WWE) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

RAD

Rite Aid

$2.69

-0.205 (-7.09%)

DERM

Dermira

$28.73

-1.44 (-4.77%)

HRC

Hill-Rom

$79.07

0.1 (0.13%)

COH

Coach

$47.47

0.61 (1.30%)

WWE

WWE

$20.71

0.17 (0.83%)

  • 10

    Jul

  • 28

    Jul

RAD Rite Aid
$2.69

-0.205 (-7.09%)

06/30/17
EVER
06/30/17
INITIATION
EVER
Underperform
Rite Aid reinstated with an Underperform at Evercore ISI
Evercore ISI analyst Ross Muken reinstated Rite Aid with an Underperform rating, versus In-Line previously, to reflect threats from online competition, structural challenges at the back-end of pharmacy given network positioning, and limited strategic options. The analyst sees downside near-term to $2.00-$2.50 per share.
06/30/17
COWN
06/30/17
NO CHANGE
Target $5
COWN
Outperform
Rite Aid better positioned following new agreement, says Cowen
Cowen analyst Charles Ryhee said he is positive on the new Rite Aid (RAD) agreement with Walgreens (WBA) as it better positions the company than had it remained stand-alone with no deal at all. Benefits include deleveraging, lower generic procurement costs, increased financial flexibility and "great" leverage toward PBM, which is growing faster than retail. Ryhee reiterated his Outperform rating and $4.70 price target on Rite Aid shares.
06/29/17
JEFF
06/29/17
NO CHANGE
Target $95
JEFF
Buy
Jefferies sees Walgreens topping new synergy target
Jefferies analyst Brian Tanquilut fully expects Walgreens Boots Alliance (WBA) to exceed its new synergy target from the purchase of Rite Aid (RAD) stores. He also expects the FTC to approve the new agreement as he thinks Walgreens wouldn't have entered into it if the agency wasn't fully aware and on-board with the revised transaction. The analyst views the recent pullback in Walgreens shares as overdone and keeps a Buy rating on the name with a $95 price target.
06/29/17
DBAB
06/29/17
NO CHANGE
Target $8
DBAB
Hold
Fred's price target lowered to $8 from $16 at Deutsche Bank
Deutsche Bank analyst Paul Trussell halved his price target for Fred's (FRED) to $8 after the company's asset purchase in connection with the failed Walgreens Boots Alliance (WBA), Rite Aid (RAD) merger was terminated. Fred's is now left to execute its pharmacy transformation organically, Trussell tells investors in a research note. He believes the company faces increasing competition in the dollar store space and keeps a Hold rating on the name.
DERM Dermira
$28.73

-1.44 (-4.77%)

06/22/17
CANT
06/22/17
INITIATION
CANT
Overweight
Dermira initiated with an Overweight at Cantor
Cantor analyst Louise Chen started coverage of Dermira with a $45 price target and a buy rating. The analyst expects the FDA to approve the company's DRM04 drug for excessive sweating in 2018, and she thinks that the company's Cimzia drug for psoriasis could gain more market share than expected.
06/29/17
EVER
06/29/17
INITIATION
Target $48
EVER
Outperform
Dermira initiated with an Outperform at Evercore ISI
Evercore analyst Umer Raffat initiated Dermira with an Outperform rating and a $48 price target.
03/30/17
MZHO
03/30/17
INITIATION
Target $42
MZHO
Buy
Dermira initiated with a Buy at Mizuho
Mizuho initiated Dermira with a Buy and a $42 price target saying it is an innovative dermatology "biotech" that may serve as a 2018 takeout target in a sector that has gained more interest by large-cap pharma companies.
03/31/17
03/31/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Market Perform at Wells Fargo. 2. Amazon.com (AMZN) was initiated with a Buy at Loop Capital while Alphabet (GOOG, GOOGL) was initiated with a Hold. 3. Dermira (DERM) initiated with a Buy at Mizuho. 4. TSYS (TSS) initiated with a Buy at Guggenheim. 5. HealthEquity (HQY) initiated with an Overweight at Cantor. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HRC Hill-Rom
$79.07

0.1 (0.13%)

06/29/17
CANT
06/29/17
INITIATION
Target $86
CANT
Neutral
Hill-Rom initiated with a Neutral at Cantor
Cantor Fitzgerald analyst Travis Steed started Hill-Rom with a Neutral rating and $86 price target.
06/30/17
NEED
06/30/17
INITIATION
Target $95
NEED
Buy
Hill-Rom initiated with a Buy at Needham
Needham analyst Mike Matson initiated Hill-Rom with a Buy and a $95 price target.
06/29/17
NEED
06/29/17
INITIATION
Target $95
NEED
Buy
Hill-Rom initiated with a Buy at Needham
Needham analyst Michael Matson started Hill-Rom with Buy rating and $95 price target.
02/08/17
LEHM
02/08/17
INITIATION
Target $70
LEHM
Overweight
Hill-Rom initiated with an Overweight at Barclays
Barclays analyst Matthew Taylor started Hill-Rom with an Overweight rating and $70 price target.
COH Coach
$47.47

0.61 (1.30%)

06/26/17
06/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coach (COH) upgraded to Buy from Neutral by Buckingham analyst Scott Krasik, who sees further upside based on expectations core margins can expand, Kate Spade accretion will exceed expectations, and thinks the company will make further additive acquisitions over the next few years. 2. Costco (COST) upgraded to Outperform from Market Perform by Raymond James analyst Budd Bugatch, who noted that the shares have pulled back approximately 13% since June 15 in reaction to Amazon's (AMZN) purchase of Whole Foods (WFM), which he views as providing a buying opportunity. 3. Pandora (P) upgraded to Sector Weight from Underweight at Pacific Crest by analyst Andy Hargreaves, who said the SiriusXM-appointed board members are likely to push for a moderated cash burn rate. The analyst believes lower cash burn, even at the expense of subscriber growth, would be a positive for Pandora. 4. UBS (UBS) upgraded to Overweight from Neutral by JPMorgan analyst Kian Abouhossein, who views the current valuation as attractive. 5. Goldman analyst Michael Lapides upgraded Duke Energy (DUK) to Buy and raised its price target to $85 from $82 saying relative valuation is compelling. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/17
BUCK
06/26/17
UPGRADE
BUCK
Buy
Coach upgraded to Buy from Neutral at Buckingham
Buckingham analyst Scott Krasik upgraded Coach to Buy and increased its price target to $58 from $45 saying he sees further upside based on expectations core margins can expand to 22%-24% from 19% by FY21, Kate Spade accretion will exceed expectations, and expects further additive acquisitions over the next few years. Krasik expects Coach to be rewarded with a higher multiple as it establishes itself as the only US based multi-brand luxury holding company.
06/15/17
RBCM
06/15/17
NO CHANGE
RBCM
Coach price target raised to $50 from $45 at RBC Capital
RBC Capital analyst Brian Tunick says that the stabilization of the growth of the North American handbag market at flar to low single digit percentage growth has increased the market's visibility. He adds that last quarter was the first in over three years in which the handbag market's growth was driven by price increases. Tunick believes that Coach's (COH) acquisition of Kate Spade (KATE) will accelerate the growth of both brands through greater scale. The analyst estimates that the deal will raise Coach's EPS by 30c-40c, and he raised his price target on the shares to $50 from $45 while keeping an Outperform rating.
06/30/17
ADAM
06/30/17
INITIATION
Target $59
ADAM
Buy
Coach initiated with a Buy at Canaccord
Canaccord Genuity analyst Camilo Lyon started Coach (COH) with a Buy rating and $59 price target. The analyst the Kate Spade (KATE) acquisition as "transformative both from a financial and portfolio evolution perspective." Lyon believes Coach is well positioned to deliver "outsized performance" over the next three years.
WWE WWE
$20.71

0.17 (0.83%)

01/12/17
01/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Xerox (XRX) assumed with an Overweight at Morgan Stanley. 2. General Dynamics (GD) and Raytheon (RTN) were initiated with an Outperform at RBC Capital, while the firm initiated Boeing (BA) with an Underperform and initiated Lockheed Martin (LMT) and United Technologies (UTX) with a Sector Perform. 3. WWE (WWE) initiated with a Buy at Guggenheim. 4. Aaron's (AAN) initiated with an Overweight at Stephens. 5. Zendesk (ZEN) initiated with an Outperform at Cowen. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/27/17
SBSH
03/27/17
INITIATION
Target $25
SBSH
Buy
WWE initiated with a Buy at Citi
Citi analyst Jason Bazinet started WWE (WWE) with a Buy rating and $25 price target. WWE's transition to a web-based subscription model should result in better growth through 2020 and increases the company's strategic value to likely suitors, such as 21st Century Fox (FOXA), Comcast (CMCSA) and Formula One (LMCA), the analyst contends.
05/05/17
MKMP
05/05/17
NO CHANGE
Target $25
MKMP
Buy
WWE weakness a buying opportunity, says MKM Partners
MKM Partners analyst Eric Handler views weakness in WWE following the mixed Q1 results and soft Q2 outlook as a buying opportunity. Handler remains positive on long-term growth and said management is confident it can produce nearly 70% adjusted OIBDA growth in 2H 2017 due to lower level of operating expenses. He mentions that churn continues to move lower and believes recent international announcements should help accelerate subscriber growth for the WWE Network in late 2017 or next year. The analyst rates WWE a Buy with a $25 price target.
06/30/17
MSCO
06/30/17
INITIATION
Target $23
MSCO
Equal Weight
WWE initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne initiated WWE with an Equal Weight and a $23 price target. The analyst sees upside in TV renewals versus consensus but is slightly more cautious on the company's ability to sustain current WWE OTT Network net add levels, as resent results indicate it is reaching maturity.

TODAY'S FREE FLY STORIES

ACRS

Aclaris Therapeutics

$29.18

-0.46 (-1.55%)

04:55
07/28/17
07/28
04:55
07/28/17
04:55
Conference/Events
Aclaris Therapeutics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

04:55
07/28/17
07/28
04:55
07/28/17
04:55
General news
Breaking General news story  »

Week of 7/28 Baker-Hughes…

04:55
07/28/17
07/28
04:55
07/28/17
04:55
General news
Consumer Sentiment Index to be reported at 10:00 »

Consumer Sentiment Index…

JAGX

Jaguar Animal Health

$0.66

-0.0175 (-2.58%)

04:55
07/28/17
07/28
04:55
07/28/17
04:55
Conference/Events
Jaguar Animal Health to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

04:55
07/28/17
07/28
04:55
07/28/17
04:55
General news
GDP price index to be reported at 08:30 »

GDP price index will be…

CALM

Cal-Maine Foods

$38.05

0.55 (1.47%)

04:55
07/28/17
07/28
04:55
07/28/17
04:55
Conference/Events
Cal-Maine Foods participates in a conference call with Stephens »

Stephens hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

04:55
07/28/17
07/28
04:55
07/28/17
04:55
General news
Real GDP to be reported at 08:30 »

Real GDP will be reported…

BAESY

BAE Systems

$32.23

0.145 (0.45%)

, IBM

IBM

$145.07

-0.29 (-0.20%)

04:55
07/28/17
07/28
04:55
07/28/17
04:55
Conference/Events
RSA Security to hold a conference »

RSA Security Conference…

BAESY

BAE Systems

$32.23

0.145 (0.45%)

IBM

IBM

$145.07

-0.29 (-0.20%)

CTL

CenturyLink

$23.60

0.74 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

04:55
07/28/17
07/28
04:55
07/28/17
04:55
General news
Breaking General news story  »

Minneapolis Federal…

04:55
07/28/17
07/28
04:55
07/28/17
04:55
General news
Employment Cost Index ECI to be reported at 08:30 »

Employment Cost Index ECI…

03:35
07/28/17
07/28
03:35
07/28/17
03:35
General news
FX Action: USD-CAD steady after posting its biggest one-day gain »

FX Action: USD-CAD steady…

01:40
07/28/17
07/28
01:40
07/28/17
01:40
General news
FX Update: The Swiss franc tumbled for a four straight session »

FX Update: The Swiss…

TOO

Teekay Offshore Partners

$2.55

-0.03 (-1.16%)

20:27
07/27/17
07/27
20:27
07/27/17
20:27
Downgrade
Teekay Offshore Partners rating change at Raymond James »

Teekay Offshore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$7.93

-1.34 (-14.46%)

20:26
07/27/17
07/27
20:26
07/27/17
20:26
Downgrade
QEP Resources rating change at JPMorgan »

QEP Resources downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 14

    Aug

RDFN

Redfin

20:26
07/27/17
07/27
20:26
07/27/17
20:26
Syndicate
Redfin 9.231M share IPO priced at $15.00 »

The deal range is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 28

    Jul

XOM

Exxon Mobil

$80.83

0.46 (0.57%)

, CVX

Chevron

$106.11

0.99 (0.94%)

20:25
07/27/17
07/27
20:25
07/27/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

XOM

Exxon Mobil

$80.83

0.46 (0.57%)

CVX

Chevron

$106.11

0.99 (0.94%)

MRK

Merck

$63.69

1.89 (3.06%)

ABBV

AbbVie

$71.73

-0.86 (-1.18%)

AAL

American Airlines

$50.00

-1.01 (-1.98%)

COL

Rockwell Collins

$109.02

-0.53 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

  • 28

    Jul

  • 28

    Jul

  • 28

    Jul

  • 28

    Jul

  • 28

    Jul

  • 07

    Aug

  • 28

    Aug

  • 22

    Sep

TTPH

Tetraphase

$6.96

-0.92 (-11.68%)

20:22
07/27/17
07/27
20:22
07/27/17
20:22
Syndicate
Tetraphase 10M share Secondary priced at $6.50 »

Piper Jaffray, BMO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

BVN

Buenaventura

$12.45

0.1 (0.81%)

19:26
07/27/17
07/27
19:26
07/27/17
19:26
Earnings
Buenaventura reports Q2 EPS (2c), may not compare to consensus 26c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAS

Basic Energy

$28.67

0.06 (0.21%)

19:02
07/27/17
07/27
19:02
07/27/17
19:02
Hot Stocks
Breaking Hot Stocks news story on Basic Energy »

Basic Energy backs FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

  • 14

    Aug

BAS

Basic Energy

$28.67

0.06 (0.21%)

19:01
07/27/17
07/27
19:01
07/27/17
19:01
Earnings
Basic Energy reports Q2 adjusted EPS (57c), consensus (55c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

  • 14

    Aug

GE

General Electric

$25.79

0.2 (0.78%)

18:55
07/27/17
07/27
18:55
07/27/17
18:55
Periodicals
Breaking Periodicals news story on General Electric »

Uber CEO shortlists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AIV

Aimco

$44.01

0.13 (0.30%)

18:53
07/27/17
07/27
18:53
07/27/17
18:53
Earnings
Aimco reports Q2 AFFO 51c vs 50c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

NOV

National Oilwell

$33.71

0.37 (1.11%)

18:43
07/27/17
07/27
18:43
07/27/17
18:43
Earnings
National Oilwell reports Q2 adjusted EPS (14c), consensus (15c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

  • 29

    Aug

AIG

AIG

$65.17

-0.02 (-0.03%)

, IEP

Icahn Enterprises

$53.12

-0.78 (-1.45%)

18:39
07/27/17
07/27
18:39
07/27/17
18:39
Periodicals
Senators worried over whether Icahn is pushing regulators on AIG, Reuters says »

U.S. Democratic Senators…

AIG

AIG

$65.17

-0.02 (-0.03%)

IEP

Icahn Enterprises

$53.12

-0.78 (-1.45%)

PRU

Prudential

$112.74

0.55 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 03

    Aug

  • 27

    Sep

HTBK

Heritage Commerce

$13.85

-0.14 (-1.00%)

18:24
07/27/17
07/27
18:24
07/27/17
18:24
Earnings
Heritage Commerce reports Q2 EPS 19c, consensus 19c »

Reports Q2 NII $24.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.